Switzerland
# |
Name |
Inventory |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.27 B
|
Dec. 31, 2023 | USD 48.28 | 3.35% |
|
Switzerland |
|
2 |
USD 141.84 M
|
Dec. 31, 2023 | USD 26.45 | -1.05% |
|
Switzerland |
|
3 |
USD 31.37 M
|
Dec. 31, 2023 | USD 45.08 | 2.29% |
|
Switzerland |
|
4 |
USD 16.18 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
5 |
USD 0.00
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
6 |
USD 0.00
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
7 |
USD 0.00
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
The Vaccines company in Switzerland with the highest Inventory is Sandoz Group AG (Swiss Stock Exchange: SDZ.SW) at USD 2.27 B.
The Vaccines company in Switzerland with the lowest Inventory is Molecular Partners AG (Swiss Stock Exchange: MOLN.SW) at USD 0.00.
The top 10 Vaccines companies in Switzerland by Inventory are Sandoz Group AG, PolyPeptide Group AG, Basilea Pharmaceutica AG, ADC Therapeutics SA, MoonLake Immunotherapeutics, AC Immune SA and Molecular Partners AG.
The bottom 10 Vaccines companies in Switzerland by Inventory are Molecular Partners AG, AC Immune SA, MoonLake Immunotherapeutics, ADC Therapeutics SA, Basilea Pharmaceutica AG, PolyPeptide Group AG and Sandoz Group AG.